Li Jia
0009-0001-9204-2843
Shanghai Institute of Materia Medica
3 papers found
Refreshing results…
YCH1899, a Highly Effective Phthalazin-1(2H)-one Derivative That Overcomes Resistance to Prior PARP Inhibitors
Thioparib inhibits homologous recombination repair, activates the type I IFN response, and overcomes olaparib resistance
Design, synthesis and pharmacological evaluation of new PARP1 inhibitors by merging pharmacophores of olaparib and the natural product alantolactone
Missing publications? Search for publications with a matching author name.